Cargando…
Differential serum protein markers and the clinical severity of asthma
BACKGROUND: Asthma is a heterogeneous disease characterized by different clinical phenotypes and the involvement of multiple inflammatory pathways. During airway inflammation, many cytokines and chemokines are released and some are detectable in the sera. OBJECTIVE: Serum chemokines and cytokines, i...
Autores principales: | Meyer, Norbert, Nuss, Sarah Janine, Rothe, Thomas, Siebenhüner, Alexander, Akdis, Cezmi A, Menz, Günter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008293/ https://www.ncbi.nlm.nih.gov/pubmed/24851055 http://dx.doi.org/10.2147/JAA.S53920 |
Ejemplares similares
-
Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air
por: Meyer, Norbert, et al.
Publicado: (2014) -
Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma
por: Cardoso‐Vigueros, Carlos, et al.
Publicado: (2022) -
Microbiome and asthma
por: Sokolowska, Milena, et al.
Publicado: (2018) -
Innate lymphoid cell subsets in obese asthma patients: Difference in activated cells in peripheral blood and their relationship to disease severity
por: Celebi Sozener, Zeynep, et al.
Publicado: (2022) -
Involvement and therapeutic implications of airway epithelial barrier dysfunction in type 2 inflammation of asthma
por: Dong, Xiang, et al.
Publicado: (2022)